| REVIEW ARTICLE
|Year : 2017 | Volume
| Issue : 1 | Page : 89-103
Indian consensus statement for treatment of advanced non small cell lung cancer: First line, maintenance, and second line
Under the aegis of Lung Cancer Consortium Asia (LCCA), Indian Cooperative Oncology Network (ICON), Indian Society of Medical & Pediatric Oncology (ISMPO), Molecular Oncology Society (MOS) and Association of Physicians of India API)
The management of advanced nonsmall cell lung cancer (NSCLC) patients is becoming complex with the identification of driver mutations and targeted therapies. The expert group of academic medical oncologists used data from published literature, practical experience to arrive at practical consensus recommendations to treat advanced NSCLC for use by the community oncologists.
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*